Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frontline sequential immunochemotherapy plus lenalidomide for mantle cell lymphoma incorporating MRD evaluation: Phase II, investigator-initiated, single-center study
    Meeting Abstract

    Epstein-Peterson, Z. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Ho, C.; Jacob, A. P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and COVID-19 severity in cancer patients
    Meeting Abstract

    Bolton, K. L.; Foote, M.; Jee, J.; Safonov, A.; Ptashkin, R.; Devlin, S.; Gedvilaite, E.; Gao, T.; Papaemmanuil, E.; Pessin, M. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A phase III trial of capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer (CAPItello290)
    Meeting Abstract

    Schmid, P.; Cortes, J.; Robson, M. E.; Iwata, H.; Hegg, R.; Nechaeva, M.; Xu, B.; Verma, S.; Haddad, V.; Imedio, E. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • KEYLYNK-009: A phase II/III, open-label, randomized study of pembrolizumab (pembro) plus olaparib vs pembro plus chemotherapy after induction with first-line pembro plus chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)
    Meeting Abstract

    Rugo, H. S.; Llombart-Cussac, A.; Andre, F.; Robson, M. E.; Saji, S.; Harbeck, N.; Schmid, P.; Cescon, D. W.; Ahn, J. S.; Nanda, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • KITE-439: A phase I study of HPV16 E7 T cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers
    Meeting Abstract

    Kirtane, K.; Massarelli, E.; Hanna, G. J.; Klebanoff, C. A.; Blumenschein, G.; Bishop, M. R.; Lee, S.; Niu, J.; Adhikary, S.; Astrow, S. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Objective and subjective vulvovaginal symptoms in breast cancer patients
    Meeting Abstract

    Goldfarb, S. B.; Saban, S.; Arkema, A.; Patil, S.; Flynn, J.; Goldfrank, D. J.; Norton, L.; Carter, J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Impact of breast cancer chemotherapy on ovarian damage and recovery
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Turan, V.; Crown, A.; Abdo, N.; Dickler, M. N.; Oktay, K.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Family building preferences among young women with invasive breast cancer
    Meeting Abstract

    Crown, A.; Abdo, N.; Noy, A.; Chang, C.; Gemignani, M.; Goldfarb, S. B.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization of chemotherapy-induced peripheral neuropathy (CIPN) using patient-reported outcomes (PRO) and quantitative sensory testing (QST)
    Meeting Abstract

    Bao, T.; Zhi, W. I.; Chen, C.; Baser, R. E.; Li, Q. S.; Panageas, K.; Harte, S.; Mao, J. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors
    Meeting Abstract

    Yuan, X.; Zhang, X.; Du, R.; Cheung, S. H.; Wei, M.; Zhou, C.; Wang, L.; Shearer, T.; Edris, B.; Smith, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save